San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Versant Ventures Launches Jecure Therapeutics With $20 Million Investment

San Francisco-based life-science investment firm Versant Ventures announced the formation of Jecure Therapeutics, a San Diego-based biotech company with a locally developed liver disease platform.

By John Cox February 16, 2017 2:44 p.m. share »

Prostate Center of San Diego to Provide Investigational Procedure

A German physician-scientist with a promising technique for treating prostate cancer has made La Jolla his beachhead for what he hopes will become a nationwide string of surgery centers.

By John Cox February 16, 2017 2:35 p.m. share »

Biocept Hires Ex-Trovagene Executive Michael Terry

Liquid biopsy company Biocept Inc. has hired ex-Trovagene executive Michael Terry to join their leadership team as senior vice president of commercial operations.

By Brittany Meiling February 16, 2017 2:27 p.m. share »

NucleusHealth Announces Pilot Project With Dana-Farber/Harvard Cancer Center

NucleusHealth, a cloud-based medical image management company based in San Diego, said it is working on a pilot project with the Dana-Farber/Harvard Cancer Center in Boston.

By John Cox February 14, 2017 4:15 p.m. share »

Ionis Earns $75 Million from Bayer

Carlsbad drugmaker Ionis Pharmaceuticals Inc. is receiving a $75 million payment from its partner Bayer to advance two anti-blood-clotting programs.

By Brittany Meiling February 14, 2017 11:30 a.m. share »

Retrophin Brings on Ex-Ardea Executive to Lead R&D

Local biotech Retrophin Inc. has hired William “Bill” Rote as senior vice president of research and development.

By Brittany Meiling February 13, 2017 4:51 p.m. share »

NuVasive Posts Record Revenue of $962.1 Million for 2016

Local medical device maker NuVasive Inc. reported strong financial performance for 2016, indicating good times are ahead for 2017.

By Brittany Meiling February 13, 2017 2:56 p.m. share »

Illumina Adds Three Startups to Accelerator Program

Local science technology company Illumina Inc. has added three new startups to its accelerator program, which mentors and invests money into early-stage companies in the genomics technology space.

By Brittany Meiling February 12, 2017 1:06 p.m. share »
Tease photo

Vividion’s Backers Give It Good Starting Point With $50M

A recent infusion of cash launched a local biotech out of stealth mode with the biggest VC backing of the year so far in San Diego.

By Brittany Meiling February 9, 2017 2:59 p.m. share »

DJO Global Getting into Software

Another local medical device firm is dabbling in software.

By Brittany Meiling February 9, 2017 2:35 p.m. share »

FDA Grants Angionetics' Therapeutic Candidate Fast-Track Status

Local gene therapy company Angionetics Inc. has been granted a Fast Track designation from the U.S. Food and Drug Administration for its lead drug candidate Generx.

By Brittany Meiling February 7, 2017 1:06 p.m. share »

GreatCall Leases New Location to Accommodate Expansion

San Diego-based GreatCall Inc. has leased a 61,000-square-foot space in Carlsbad it plans to expand into in May.

By John Cox February 7, 2017 6 a.m. share »
Tease photo

Group Buying Genoptix’s Diagnostic Business

Ownership of the Genoptix name is changing hands again as the company’s commercial laboratory is peeled off from its other operations in Carlsbad.

By Brittany Meiling February 6, 2017 midnight share »

Acadia's Stock Gets Boost From Speculation Over Possible Acquisition

The stock of San Diego drugmaker Acadia Pharmaceuticals Inc. is on the rise Feb. 3 following speculation of a takeover bid by Big Pharma AstraZeneca.

By Brittany Meiling February 3, 2017 1:20 p.m. share »

Ionis Earns $5 Million from Biogen

Local drugmaker Ionis Pharmaceuticals Inc. has earned $5 million in a milestone payment from Biogen, a global giant in biotechnology and one of Ionis’ many partners.

By Brittany Meiling February 2, 2017 3:51 p.m. share »